TriSalus Life Sciences, Inc. — Form D

TriSalus Life Sciences, Inc. of WESTMINSTER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2024-12-30. The offering totals $1000K, of which $1000K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (36)

Showing 25 of 36 people.

NameRoleLocation
Arjun B DesaiDirectorWestminster, CO
Kerry B HicksDirectorWestminster, CO
Liselotte B HyveledDirectorWestminster, CO
George Kelly MartinDirectorWestminster, CO
David Kelly MatlinDirectorWestminster, CO
Andrew B von EschenbachDirectorWestminster, CO
Mats Kelly WahlstromDirectorWestminster, CO
Bryan F CoxExecutive OfficerWestminster, CO
Jodi Kelly DevlinExecutive OfficerWestminster, CO
Richard B MarshakExecutive OfficerWestminster, CO
Sean MurphyExecutive OfficerSan Diego, CA
Jennifer E StevensExecutive OfficerWestminster, CO
Karim KartiDirectorMenlo Park, CA
Jennifer J StevensExecutive OfficerWestminster, CO
David J MatlinDirectorWestminster, CO
David J MatlinExecutive OfficerWestminster, CO
Jodi J DevlinExecutive OfficerWestminster, CO
Arjun F DesaiDirectorWestminster, CO
Sean MurphyDirectorSan Diego, CA
Richard J MarshakExecutive OfficerWestminster, CO
Gary F GordonDirectorWestminster, CO
James YoungExecutive OfficerWestminster, CO
Mary SzelaDirectorWestminster, CO
Mary SzelaExecutive OfficerWestminster, CO
Andrew F von EschenbachDirectorWestminster, CO

Other filings by this issuer (2)

FiledFormOfferingSold
2025-05-08D$22.0M$22.0M
2023-06-22D$50.0M$17.9M

More